OPCH Option Care Health, Inc.
USHealthcareAs of 2026-07-09 16:00
Why OPCH matters now
Option Care Health, Inc. (OPCH) is a US stock in Healthcare. The latest InvestLog snapshot shows $21.67 with +0.93% on the session and $3.40B in market capitalization; recent performance reads 1-month +5.42% and YTD -30.98%.
The latest financial table shown here is Q1 2026, with revenue of $1.35B, net income of $45.3M, and EPS of $0.29. Investors can compare that operating picture with valuation signals such as P/E 21.21 and FCF yield 6.8%.
The latest indexable market news headline is "Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $30.00; recent insider activity includes BRANDT ERIC filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
21.21
PEG
—
P/B
2.55
P/S
0.61
EV/EBITDA
11.05
DCF Value
$96.04
FCF Yield
6.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.0%
Operating Margin
5.9%
Net Margin
3.6%
ROE
15.3%
ROA
6.1%
ROIC
9.2%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $1.35B | $45.3M | $0.29 |
| Q4 2025 | $1.47B | $58.5M | $0.37 |
| FY 2025 | $5.65B | $207.6M | $1.27 |
| Q3 2025 | $1.44B | $51.8M | $0.32 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$31.22
Target (Median)
$30.00
Target Range
$22.00 - $39.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
—
Beta
0.65
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.